Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma

Optimal treatment duration: When is it safe to stop?

Date

07 Dec 2024

Session

Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma

Topics

Tumour Site

Melanoma

Presenters

Astrid van der Veldt

Authors

A.A.M. van der Veldt

Author affiliations

  • Medical Oncology Department, Erasmus MC - University Medical Center, 3015 CE - Rotterdam/NL

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Efficacy of low-dose ICI

Presenter: Amol Patel

Session: Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma

Resources:

Slides

Webcast

Novel ICI combinations

Presenter: Ana Maria Arance

Session: Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma

Resources:

Slides

Webcast

Q&A and discussion

Session: Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.